Ironwood Pharmaceuticals, Inc. - Class A Common Stock (NQ:IRWD)

Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

February 29, 2024

Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results.

Via Benzinga

Earnings Scheduled For February 15, 2024 ↗

February 15, 2024

Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million.

Via Benzinga

A Preview Of Ironwood Pharmaceuticals's Earnings ↗

February 14, 2024

Via Benzinga

Chart Of The Day: Ironwood Pharma - Gastrointestinal Products ↗

February 13, 2024

Via Talk Markets

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

February 29, 2024

Via Benzinga

Stocks Mixed, Headed For Monthly Wins ↗

February 29, 2024

In what appears to be a theme this week, stocks are hesitant midday as investors unpack this morning's jobs and inflation data.

Via Talk Markets

Topics Economy

Why Is Gastrointestinal Healthcare Focused Ironwood Pharmaceuticals Stock Sinking On Thursday? ↗

February 29, 2024

Ironwood Pharmaceuticals' SBS-IF treatment Apraglutide's Phase 3 trial met primary endpoints, reducing PS dependency by 25.5% vs. placebo, but misses on two key secondary endpoints.

Via Benzinga

Nasdaq Gains 100 Points Following PCE Data ↗

February 29, 2024

U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 100 points on Thursday. Following the market opening Thursday, the Dow traded down 0.07% to 38,923.11 while the...

Via Benzinga

Topics Stocks

PSNY Stock Alert: Polestar Makes Moves With Its Joint Venture ↗

February 29, 2024

Polestar stock is rising higher on Thursday as holders of PSNY shares react to an update for the company's Chinese joint venture.

The company still plans to ask for approval of its short bowel syndrome treatment.

Ironwood Pharmaceuticals Ran Up 32% Over Two Months — And Just Lost It All ↗

February 29, 2024

Via Investor's Business Daily

Tech Stocks Set To Rise Thursday As January Inflation Data Fails To Scare Markets, Small Caps Surge ↗

February 29, 2024

Tech stocks drive pre-market surge, Fed inflation data fails to disrupt rate cut expectations. Futures up for Nasdaq, S&P 500, and small caps.

Via Benzinga

Topics Economy Stocks

Why Is Ironwood Pharmaceuticals (IRWD) Stock Down 27% Today? ↗

February 29, 2024

Ironwood Pharmaceuticals stock is falling on Thursday with investors in IRWD unimpressed by its latest Phase III clinical trial results.

It's time to dive into the biggest pre-market stock movers for Thursday as we check out all of the news affecting shares this morning!

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

February 29, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

February 29, 2024

Ironwood Pharmaceuticals Announces Positive Topline Results from Global Phase III Trial of Once-Weekly Apraglutide in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)

February 29, 2024

Ironwood Pharmaceuticals to Present Four Abstracts at the ASPEN 2024 Nutrition Science & Practice Conference

February 23, 2024

As of Feb. 15, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Top 4 Health Care Stocks You May Want To Dump In February ↗

February 15, 2024

Via Benzinga

Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial Guidance

February 15, 2024

Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2023 Investor Update Call

February 01, 2024

Ironwood Announces Publication in The Lancet Gastroenterology & Hepatology of New Linaclotide Phase III Data in Children and Adolescents Aged 6-17 Years with Functional Constipation

January 08, 2024

Ironwood Pharmaceuticals Maintains FY 2023 Financial Guidance and Announces FY 2024 Financial Guidance

January 08, 2024

Ironwood Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

January 03, 2024

Ironwood Announces the Completion of Squeeze-Out Merger With VectivBio

December 12, 2023

Stonegate Healthcare Partners Releases Report on Transformative Therapies for Pruritus Management

November 30, 2023

Dallas, Texas--(Newsfile Corp. - November 30, 2023) - Stonegate Healthcare Partners is pleased to...

Via Newsfile

Ironwood Pharmaceuticals to Participate in the Piper Sandler 35th Annual Healthcare Conference

November 21, 2023

Ironwood Pharmaceuticals Reports Third Quarter 2023 Results

November 09, 2023

Ironwood Pharmaceuticals to Host Third Quarter 2023 Investor Update Call

October 26, 2023

Ironwood Releases New IBS-C and CIC Data at the American College of Gastroenterology 2023 Annual Scientific Meeting

October 23, 2023

Ironwood Pharmaceuticals Presents Positive Final Data from STARS Nutrition, a Phase II Study of Apraglutide in Short Bowel Syndrome with Intestinal Failure (SBS-IF) and Colon in Continuity (CIC) at United European Gastroenterology Week

October 16, 2023